Showing results (121-130 of 409) with videos related to

Sort By:
Pageof 41
Pharmacogenomics|March 21, 2022
KCNQ1 variant rs163184 is a potential biomarker of glycemic response to exenatideZhaoxu Geng, Qian Li, Rong Huang, et al.
Zhonghua Yi Xue Za Zhi|June 18, 2015
[Glucose characteristics in normal glucose tolerance subjects with metabolic syndrome]Xubin Yang, Yanhua Zhu, Sihui Luo, et al.
Clinical Endocrinology|January 28, 2009
Hyperinsulinaemic hypoglycaemia associated with a heterozygous missense mutation of R1174W in the insulin receptor (IR) geneZhimin Huang, Yanbing Li, Tianyi Tang, et al.
Zhonghua Yi Xue Za Zhi|November 18, 2014
[Insulin requirement profiles and related factors of type 2 diabetics with insulin pump therapy]Xiuzhen Zhang, Lin Yao, Hongrong Deng, et al.
The Journal of Endocrinology|May 29, 2019
Exenatide mitigates inflammation and hypoxia along with improved angiogenesis in obese fat tissueYingxin Xian, Zonglan Chen, Hongrong Deng, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|April 21, 2022
Advances of functional nanomaterials for magnetic resonance imaging and biomedical engineering applicationsRuijie Huang, Xingyu Zhou, Guiyuan Chen, et al.
International Journal of Endocrinology|June 26, 2019
Liraglutide Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism via SHP1/AMPK Signaling PathwayPeng Yu, Xi Xu, Jing Zhang, et al.
Science China. Life Sciences|June 15, 2019
Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetesXubin Yang, Hongrong Deng, Xiuzhen Zhang, et al.
Journal of Diabetes|May 10, 2014
China type 2 diabetes treatment status survey of treatment pattern of oral drugs usersLinong Ji, Juming Lu, Jianping Weng, et al.
Pageof 41